Tat-Smad7 does not impairthe therapeutic efficacy of radiotherapy on adjacent oral cancer cells, instead increasing oxidative stress and apoptosis, supportingits safe use in clinical oncology settings [10]. The gene discussed is SMAD7; the disease is lip and oral cavity carcinoma.